Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.45 USD | +27.29% |
|
-.--% | -.--% |
10/05 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
09/05 | Chandra Asri purchase of Shell Singapore refinery brings scale, risk | RE |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- Low profitability weakens the company.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 1342.79 times its estimated earnings per share for the ongoing year.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- Most analysts recommend that the stock should be sold or reduced.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 48.81B | - | ||
+2.31% | 99.64B | A- | ||
-11.62% | 59.01B | A- | ||
+5.26% | 34.94B | B | ||
+0.61% | 31.15B | A- | ||
+3.47% | 18.62B | B- | ||
+17.33% | 17.44B | C+ | ||
+5.92% | 13.51B | B- | ||
-6.67% | 12.73B | B | ||
-25.86% | 12.04B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TPIA Stock
- PTCAY Stock
- Ratings PT Chandra Asri Pacific Tbk